Hello, Fool! | Login | Signup | My Fool
Oct 11, 2008 3:34 AM ET | Feedback | Site Changes | Help
View All Commentary (ABII)
Recs
TMFBiologyFool (99.24) Submitted: 3/27/08 1:11 AM : Start Price: $60.25 ABII Score: 21.71
One drug on the market with a nice platform to build similar drugs. The spin off (and ticker change) has made this an unknown company which could cause its stock price to falter a little. Still there's points to be made in unknown companies.Holding the actual dollars away from this one until it gets regular with its earnings announcements. We're less than a week away from the end of the 1st quarter and there's no sign of 4th quarter financial info. The spin off is holding things up, but I figure it makes since to invest in companies based on current information.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.